ArticleBreast cancer research and treatment2019

miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.

Jieun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.